stockrow
Friday 6 November 2026
Export SYK’s income statement to Excel — free account
Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
324.50
10.58
−3.16%
Follow SYK
Alert me
Stryker Corporation (SYK) SEC filings, changes and red flags
Red flags
-
Officer departure
Stryker Corporation reported the departure of its Chief Executive Officer
-
Impairment
Stryker Corporation recorded a goodwill impairment of $456.0 million in fiscal 2024
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 30, 2026 |
P1I2: 94 added · 43 removed · 81 modified P2I1A: no changes |
||
| 8-K | Oct 29, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 6, 2026 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | Officer departure | |
| 10-Q | Jun 30, 2026 |
P1I2: 122 added · 84 removed · 60 modified P2I1A: no comparison — the Item could not be matched reliably |
||
| 8-K | Jul 30, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jun 26, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | May 15, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2026 |
P1I2: 114 added · 180 removed · 81 modified P2I1A: 173 added |
||
| 8-K | May 6, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 8-K | Apr 30, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K/A | Mar 11, 2026 | 1.05 Material cybersecurity incident; 7.01 Regulation FD disclosure | ||
| 8-K | Mar 23, 2026 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Mar 12, 2026 | 7.01 Regulation FD disclosure | ||
| 8-K | Mar 11, 2026 | 8.01 Other events | ||
| 10-K | Dec 31, 2025 |
1: no comparison — the Item could not be matched reliably 1A: no comparison — the Item could not be matched reliably 7: 708 added · 84 removed · 11 modified |
||
| 8-K | Jan 29, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 4, 2025 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2025 |
P1I2: 37 added · 30 removed · 77 modified P2I1A: no changes |
||
| 8-K | Oct 30, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 |
P1I2: 100 added · 20 removed · 52 modified P2I1A: no changes |
||
| 8-K | Jul 31, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2025 | |||
| 8-K | May 1, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 |
1: no comparison — no earlier filing on file 1A: no comparison — no earlier filing on file 7: no comparison — no earlier filing on file |
Impairment | |
| 8-K | Jan 28, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Oct 29, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Jul 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits |